Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: June

Request Number: A-2023-001220

Request Summary: Correspondence relating to any abbreviated new drug submission (ANDS) filed since July 1, 2023 where the medicinal ingredient is liraglutide alone and the indication includes the treatment of adults with type 2 diabetes.

Disposition: Disclosed in part

Number of pages: 5

Date modified: